Drug Discovery and Toxicity Screening
Discovering a new drug is difficult, tedious and expensive process, it can take up-to years and number of failures to develop a new successful drug. In spite of this, many drugs fail later in the screening processes due to unseen toxic effects and side effects. Hence selection of appropriate models and assays to check on target is necessary to predict the toxicity at early stages and designing new paths in developing new successful drug. Early toxicity screening may help in eliminating the drugs which are not eligible for drug development processes.
- Preclinical Drug Development
- Preclinical Safety Assessment
- Toxocological Testing
- Predictive Toxicology
- Drug Safety Biomarkers
Related Conference of Drug Discovery and Toxicity Screening
Drug Discovery and Toxicity Screening Conference Speakers
Recommended Sessions
- Applied Pharmacology
- Biochemical and Molecular Toxicology
- Cancer and Chemical Carcinogenesis
- Clinical Pharmacology and Pharmacotherapeutics
- Current Advances in Pharmacology
- Drug Discovery and Toxicity Screening
- Drug Toxicology
- Environmental and Ecotoxicology
- Experimental and Toxicological Pathology
- Food Safety and Toxicology
- Genetic Toxicology
- Human Health and Toxicology
- In-vitro and In-vivo Toxicology
- Industrial and Occupational Toxicology
- Pharmacology
- Product Development Toxicology
- Toxicity Testing Methods
- Toxicologic Risk Assessment
- Toxicology
- Trending Toxicology Concepts